1033777-85-3

Basic information

• Product Name: 2-hydroxy-2-(4-(trifluoromethyl)phenyl)acetyl chloride
• Synonyms: 2-hydroxy-2-(4-(trifluoromethyl)phenyl)acetyl chloride
• CAS NO: 1033777-85-3
• Molecular Weight: 238.594
• Mol File: 1033777-85-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-hydroxy-2-(4-(trifluoromethyl)phenyl)acetyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-hydroxy-2-(4-(trifluoromethyl)phenyl)acetyl chloride(1033777-85-3)
• EPA Substance Registry System: 2-hydroxy-2-(4-(trifluoromethyl)phenyl)acetyl chloride(1033777-85-3)

Safety Data

• Hazardous Substances Data: 1033777-85-3(Hazardous Substances Data)

Upstream product

• 395-35-7 4-(trifluoromethyl)mandelic acid 

Downstream Products

• 1033777-09-1 N-(3-benzyloxyphenyl)-2-hydroxy-2-(4-trifluoromethylphenyl)acetamide 
• 1033777-11-5 2-hydroxy-N-(4-imidazol-1-ylphenyl)-2-(4-trifluoromethylphenyl)acetamide 
• 1033776-91-8 2-hydroxy-N-(4-methoxycyclohexyl)-2-(4-trifluoromethylphenyl)acetamide 
• 1033776-87-2 4-[2-hydroxy-2-(4-trifluoromethylphenyl)acetylamino]-N-(2-morpholin-4-ylethyl)benzamide 
• 1210859-39-4 2-Hydroxy-1-(2-phenyl-pyrrolidin-1-yl)-2-(4-trifluoromethyl-phenyl)-ethanone 
• 1208225-47-1 2-Hydroxy-N-(isoquinolin-5-yl)-2-(4-(trifluoromethyl)phenyl)acetamide 

Relevant articles and documents

Cold Menthol Receptor Antagonists

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, L, Q, R1, R2, and R3 /s

SOLUBLE EPOXIDE HYDROLASE INHIBITORS

Disclosed are alpha keto amide and alpha hydroxy amide compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.